Meeder Asset Management Inc Vanda Pharmaceuticals Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 6,852 shares of VNDA stock, worth $34,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,852

Previous 6,852 -0.0%

Holding current value

$34,122

Previous $38,000 15.79%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$3.91 - $6.5 $26,791 - $44,538	6,852 New	6,852 $38,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $368 - $458	39 Added 33.91%	154 $2,000
Q2 2022 Aug 08, 2022	BUY	$9.31 - $11.84 $456 - $580	49 Added 74.24%	115 $1,000
Q1 2022 May 10, 2022	BUY	$10.84 - $16.55 $715 - $1,092	66 New	66 $1,000
Q4 2021 Feb 11, 2022	SELL	$15.69 - $21.14 $69,585 - $93,755	-4,435 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$15.35 - $21.27 $66,342 - $91,928	4,322 Added 3824.78%	4,435 $77,000
Q2 2021 Aug 09, 2021	SELL	$15.71 - $21.51 $13,824 - $18,928	-880 Reduced 88.62%	113 $2,000
Q1 2021 Apr 28, 2021	BUY	$13.42 - $20.28 $13,017 - $19,671	970 Added 4217.39%	993 $14,000
Q4 2020 Feb 09, 2021	SELL	$9.77 - $13.81 $55,083 - $77,860	-5,638 Reduced 99.59%	23 $0
Q3 2020 Nov 02, 2020	BUY	$9.32 - $12.02 $23,318 - $30,074	2,502 Added 79.2%	5,661 $55,000
Q2 2020 Aug 11, 2020	BUY	$9.66 - $12.02 $21,821 - $27,153	2,259 Added 251.0%	3,159 $36,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $72,495 - $162,388	-9,666 Reduced 91.48%	900 $9,000
Q4 2019 Feb 13, 2020	BUY	$12.38 - $17.47 $66,245 - $93,481	5,351 Added 102.61%	10,566 $173,000
Q3 2019 Oct 17, 2019	BUY	$12.27 - $15.79 $60,307 - $77,607	4,915 Added 1638.33%	5,215 $69,000
Q2 2019 Aug 05, 2019	SELL	$13.37 - $18.85 $106,853 - $150,649	-7,992 Reduced 96.38%	300 $4,000
Q1 2019 Apr 16, 2019	BUY	$17.59 - $31.05 $3,060 - $5,402	174 Added 2.14%	8,292 $153,000
Q4 2018 Jan 17, 2019	SELL	$18.97 - $31.47 $62,582 - $103,819	-3,299 Reduced 28.9%	8,118 $211,000
Q3 2018 Nov 02, 2018	BUY	$18.25 - $23.0 $129,611 - $163,346	7,102 Added 164.59%	11,417 $0
Q2 2018 Jul 24, 2018	BUY	$13.95 - $19.15 $18,037 - $24,760	1,293 Added 42.79%	4,315 $0
Q1 2018 May 03, 2018	SELL	$14.05 - $20.2 $6,364 - $9,150	-453 Reduced 13.04%	3,022 $50,000
Q4 2017 Feb 02, 2018	BUY	$12.85 - $18.1 $6,720 - $9,466	523 Added 17.72%	3,475 $53,000
Q3 2017 Oct 20, 2017	BUY	$15.4 - $18.85 $45,460 - $55,645	2,952	2,952 $53,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $282M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Vanda Pharmaceuticals Inc. Transaction History